PL381730A1 - Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowania - Google Patents
Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowaniaInfo
- Publication number
- PL381730A1 PL381730A1 PL381730A PL38173007A PL381730A1 PL 381730 A1 PL381730 A1 PL 381730A1 PL 381730 A PL381730 A PL 381730A PL 38173007 A PL38173007 A PL 38173007A PL 381730 A1 PL381730 A1 PL 381730A1
- Authority
- PL
- Poland
- Prior art keywords
- obtaining
- manner
- application
- bacteriophage preparation
- purified bacteriophage
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL381730A PL212099B1 (pl) | 2007-02-09 | 2007-02-09 | Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowanie |
US12/449,418 US9255251B2 (en) | 2007-02-09 | 2008-02-08 | Purified bacteriophage, its preparation and application |
DK08712679.3T DK2117568T3 (en) | 2007-02-09 | 2008-02-08 | Purified bacteriophage, its preparation and use |
PL08712679T PL2117568T3 (pl) | 2007-02-09 | 2008-02-08 | Oczyszczony bakteriofag, jego otrzymywanie i zastosowanie |
EP08712679.3A EP2117568B1 (en) | 2007-02-09 | 2008-02-08 | Purified bacteriophage, its preparation and application |
PCT/PL2008/000013 WO2008097115A1 (en) | 2007-02-09 | 2008-02-08 | Purified bacteriophage, its preparation and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL381730A PL212099B1 (pl) | 2007-02-09 | 2007-02-09 | Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowanie |
Publications (2)
Publication Number | Publication Date |
---|---|
PL381730A1 true PL381730A1 (pl) | 2008-08-18 |
PL212099B1 PL212099B1 (pl) | 2012-08-31 |
Family
ID=39495222
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL381730A PL212099B1 (pl) | 2007-02-09 | 2007-02-09 | Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowanie |
PL08712679T PL2117568T3 (pl) | 2007-02-09 | 2008-02-08 | Oczyszczony bakteriofag, jego otrzymywanie i zastosowanie |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08712679T PL2117568T3 (pl) | 2007-02-09 | 2008-02-08 | Oczyszczony bakteriofag, jego otrzymywanie i zastosowanie |
Country Status (5)
Country | Link |
---|---|
US (1) | US9255251B2 (pl) |
EP (1) | EP2117568B1 (pl) |
DK (1) | DK2117568T3 (pl) |
PL (2) | PL212099B1 (pl) |
WO (1) | WO2008097115A1 (pl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101501927B (zh) * | 2006-04-27 | 2013-09-04 | 泰科电子服务有限责任公司 | 基于异向材料结构的天线、设备和系统 |
US7592957B2 (en) * | 2006-08-25 | 2009-09-22 | Rayspan Corporation | Antennas based on metamaterial structures |
US7855696B2 (en) * | 2007-03-16 | 2010-12-21 | Rayspan Corporation | Metamaterial antenna arrays with radiation pattern shaping and beam switching |
KR101297314B1 (ko) | 2007-10-11 | 2013-08-16 | 레이스팬 코포레이션 | 단일층 금속화 및 비아-레스 메타 물질 구조 |
PL213166B1 (pl) * | 2008-10-29 | 2013-01-31 | Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk | Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów |
PL212796B1 (pl) * | 2008-11-07 | 2012-11-30 | Inst Immunologii I Terapii Doswiadczalnej Pan | Diagnostyczny preparat immunologiczny oraz jego zastosowanie |
GB2466177A (en) * | 2008-12-03 | 2010-06-16 | Arab Science & Technology Found | Bacteriophage selection and breeding |
EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
CA2901690A1 (en) | 2014-08-27 | 2016-02-27 | The Governors Of The University Of Alberta | Bacteriophage-based biosensor for microbial detection |
RU2613423C1 (ru) * | 2015-12-28 | 2017-03-16 | Евгений Олегович Рубальский | Способ получения бактериофага |
CN107893058A (zh) * | 2017-11-20 | 2018-04-10 | 大连雅立峰生物制药有限公司 | 一种去除疫苗制品中内毒素的方法 |
CN109593728A (zh) * | 2018-11-17 | 2019-04-09 | 菲吉乐科(南京)生物科技有限公司 | 一种噬菌体絮凝剂及其在发酵后处理工艺中的应用 |
CN114450398A (zh) * | 2019-10-01 | 2022-05-06 | 自适应噬菌体治疗公司 | 纯化噬菌体粒子的方法 |
CN112175915B (zh) * | 2020-10-12 | 2022-11-18 | 上海市公共卫生临床中心 | 一种噬菌体制剂中内毒素的去除方法及应用 |
CN116987577A (zh) * | 2023-09-27 | 2023-11-03 | 深圳国家感染性疾病临床医学研究中心 | 一种低内毒素噬菌体制剂的制备方法及其制备系统 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589591A (en) * | 1986-07-03 | 1996-12-31 | Advanced Magnetics, Inc. | Endotoxin-free polysaccharides |
GB2327945A (en) | 1997-07-31 | 1999-02-10 | Medeva Europ Ltd | Removal of endotoxin from vaccines |
CA2304123A1 (en) | 2000-04-19 | 2001-10-19 | Mount Sinai Hospital | Antibacterial therapy for multi-drug resistant bacteria |
PL354822A1 (pl) * | 2002-06-30 | 2004-01-12 | Instytut Immunologii i Terapii Doświadczalnej PANwe Wrocławiu | Sposób otrzymywania oczyszczonych preparatów bakteriofagowych oraz nowe zastosowania polisacharydu lub jego estryfikowanej pochodnej |
EP1663302B1 (en) * | 2003-09-03 | 2012-06-13 | Alpharma, LLC | Method for vaccination of poultry by bacteriophage lysate |
-
2007
- 2007-02-09 PL PL381730A patent/PL212099B1/pl unknown
-
2008
- 2008-02-08 DK DK08712679.3T patent/DK2117568T3/en active
- 2008-02-08 EP EP08712679.3A patent/EP2117568B1/en not_active Not-in-force
- 2008-02-08 US US12/449,418 patent/US9255251B2/en active Active
- 2008-02-08 PL PL08712679T patent/PL2117568T3/pl unknown
- 2008-02-08 WO PCT/PL2008/000013 patent/WO2008097115A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
PL2117568T3 (pl) | 2017-01-31 |
EP2117568B1 (en) | 2016-08-03 |
WO2008097115A1 (en) | 2008-08-14 |
EP2117568A1 (en) | 2009-11-18 |
US9255251B2 (en) | 2016-02-09 |
US20110008873A1 (en) | 2011-01-13 |
DK2117568T3 (en) | 2016-11-21 |
PL212099B1 (pl) | 2012-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL381730A1 (pl) | Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowania | |
HK1199031A1 (en) | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof 2--5--1,2,4- | |
IL254218A0 (en) | Pipedrine-bridged compounds of the quinoxaline-converted type and their use | |
EP2124550A4 (en) | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND THEIR USE | |
IL210722A0 (en) | Benzazepine derivatives, compositions comprising the same and uses thereof | |
ZA201000588B (en) | Improved pharmaceutical-coated medical products,the production thereof and the use thereof | |
EP2350476A4 (en) | ROTATING JOINT ASSEMBLY, CROCHET-ATTACHMENT COMBINATION AND JEWELRY USING THE SAME | |
HK1130489A1 (en) | Substituted-quinoxaline-type-piperidine compounds and the uses thereof | |
EP2253625A4 (en) | PYRIDAZINONES, PREPARATION AND USE THEREOF | |
HK1151791A1 (en) | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | |
GB2451750B (en) | Modified bacteriophage | |
EP2192122A4 (en) | Dithiolopyrrolone compounds and their preparation and use | |
EP2194062A4 (en) | CYCLIC HEPTAPEPTIDE AND USE THEREOF | |
PL383157A1 (pl) | Sposób otrzymywania monochloropropandioli i dichloropropanoli | |
PL383867A1 (pl) | Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej | |
PL382914A1 (pl) | Nowe sililopodstawione 1,2-alkiny oraz sposób otrzymywania sililopodstawionych 1,2-alkinów | |
PL383630A1 (pl) | Nowy propionian S-(-)-3,5,5-trimetylocykloheks-2-enylu i sposób jego otrzymywania | |
PL383170A1 (pl) | Sposób otrzymywania preparatu wapniowego | |
PL382237A1 (pl) | Nowe germylopodstawione 1, 2-alkiny oraz sposoby otrzymywania germylopodstawionych 1, 2-alkinów | |
PL383161A1 (pl) | N-N-dialkilowe pochodne 2-amino-2-deoksy-D- glukitolo-6- fosforanu i sposób ich otrzymywania | |
EP2117313A4 (en) | PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEM | |
PL381879A1 (pl) | Postać preparatu farmaceutycznego oraz sposób jej otrzymywania | |
PL387386A1 (pl) | Nowy związek 2-hydroksy-9-oksabicyklo [4.3.0] nonan-8-on i sposób jego otrzymywania | |
PL387384A1 (pl) | Nowy związek 2-hydroksy-4-metylo-9-oksabicyklo [4.3.0] nonan-8-on i sposób jego otrzymywania | |
PL387385A1 (pl) | Nowy związek 2-hydroksy-5, 5-dimetylo-9-oksabicyklo [4.3.0] nonan-8-on i sposób jego otrzymywania |